496
Participants
Start Date
November 18, 2022
Primary Completion Date
February 20, 2024
Study Completion Date
February 20, 2024
Lorecivivint
One intra-articular injection of 0.07 mg lorecivivint in 2 mL vehicle
Placebo
One intra-articular injection of 0 mg lorecivivint in 2 mL vehicle
DelRicht Research - Rockville, Rockville
Clinical Trials of South Carolina, Charleston
Piedmont Research Partners, LLC, Fort Mill
Pinnacle Trials, Inc., Stockbridge
Premier Medical Associates, The Villages
Conquest Research, LLC, Winter Park
Eastern Research, Inc., Hialeah
TecTum Research, Hollywood
Columbus Clinical Services, LLC, Miami
AppleMed Research Group, LLC, Miami
Advance Medical Research Center, Miami
Health and Life Research Institute, LLC, Miami
BioMed Research and Medical Center, Miami
South Florida Research Phase I-IV, Inc., Miami Springs
Unique Clinical Trials, Doral
Well Pharma Medical Research, Corp, Miami
Tampa Pain Relief Center, Tampa
Hightop Medical Research Center, Cincinnati
MediSphere Medical Research Center, LLC, Evansville
Oakland Medical Research, Troy
Health Concepts, Rapid City
Chicago Clinical Research Institute, Chicago
Healthcare Research Network, Hazelwood
DelRicht Research, New Orleans
DelRicht Research - Mandeville, Mandeville
DelRicht Research - Prairieville, Prairieville
Conrad Clinical Research, Edmond
DelRicht Research - Tulsa, Tulsa
Clinical Investigations of Texas, Plano
Zenos Clinical Research, Dallas
Synergy Groups Medical, LLC, Houston
Synergy Groups Medical, LLC, Houston
Diagnostic Research Group, San Antonio
Wasatch Clinical Research, LLC, Salt Lake City
Tucson Orthopaedic Institute, Tucson
Albuquerque Clinical Trials, Albuquerque
Core Healthcare Research, Cerritos
Millennium Clinical Trials, LLC, Thousand Oaks
Dream Team Clinical Research, Pomona
BioSolutions Clinical Research Center, La Mesa
Artemis Institute for Clinical Research, San Diego
Infinity Clinical Research, Norco
Encompass Clinical Research, Spring Valley
Skylight Health Research, Burlington
Lead Sponsor
NBCD A/S
INDUSTRY
Biosplice Therapeutics, Inc.
INDUSTRY